ZOLL Medical Corporation Receives FDA Marketing Clearance for M Series with Real CPR Help Technology
CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of resuscitation devices and related software solutions, today announced that it received clearance from the U.S. Food and Drug Administration (FDA) to market and sell the ZOLL M Series® with Real CPR Help™ technology. ZOLL’s Real CPR Help allows rescuers to instantly see and hear how well they are performing the rate and depth of CPR chest compressions. The M Series is the Company’s best-selling product to date. This approval extends Real CPR Help to ZOLL’s complete defibrillator product line.
“Virtually all of the products we market now incorporate Real CPR Help technology to improve the quality of CPR that rescuers provide,” said Richard A. Packer, President and Chief Executive Officer of ZOLL. “Not only are we installing Real CPR Help into our new products, but we are also making it available to our installed base so that customers can upgrade their existing technology and remain current with the latest resuscitation guidelines. Having Real CPR Help in the M Series will provide critical functionality that allows users to improve their resuscitation efforts, which can help improve overall survival rates.”
All cardiac arrest victims need immediate and effective CPR. Furthermore, less than half of these victims require defibrillation initially since they are experiencing heart rhythms that are not “shockable.” The critical action is CPR, which achieves minimal but effective blood flow to feed oxygen to the heart and brain. CPR is also associated with a return of a “shockable” heart rhythm, making defibrillation possible later in the resuscitation event.
Sudden cardiac arrest (SCA) is an abrupt disruption of the heart’s function, which causes a lack of blood flow to vital organs. This lack of blood flow can result in the loss of blood pressure, pulse, and consciousness. SCA is the leading cause of unexpected death in the world and strikes without warning. In the U.S. alone, there are more than 460,000 deaths each year from out-of-hospital cardiac arrest. Currently, only about 6 percent of victims survive.
About ZOLL Medical Corporation
ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation. With products for pacing, defibrillation, circulation, ventilation, and fluid resuscitation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information.
ZOLL markets and sells its products in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.
Certain statements contained in this press release regarding matters that are not historical facts are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, ZOLL’s ability to compete in the resuscitation business; acceptance of its recently launched products; changes in regulations affecting the healthcare industry; global economic conditions; and those other factors discussed in the section entitled “Risk Factors” in ZOLL’s Quarterly Report on Form 10-Q, which was filed with the SEC on February 9, 2007.
©2007 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. Real CPR Help is a trademark of ZOLL Medical Corporation. M Series and ZOLL are registered trademarks of ZOLL Medical Corporation. All product names are the property of their respective owners.
ZOLL Medical Corporation INVESTOR CONTACT: A. Ernest Whiton, +1-978-421-9655 Chief Financial Officer or
MEDIA CONTACT: Susan Schumacher, +1-978-421-9787 firstname.lastname@example.org